Magritek has introduced its qIDsolve benchtop nuclear magnetic resonance (NMR) software package for identifying, referencing, and databasing synthetic drugs and new psychoactive substances using benchtop NMR instruments.
qlDsolve is designed with automated data acquisition, identification, quantification, and reporting capabilities embedded in a fully traceable environment, according to Aachen, Germany-based Magritek. For forensic and other laboratories, the product benefits from the company's benchtop NMR spectra database containing 1,500 compounds. These compounds, which are used in drug enforcement activities, have been collected over the past 10 years through the cooperation of partners and laboratories around the world.
In its announcement, Magritek noted that NMR spectroscopy is recognized by the Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) as a Category A analytical technique. NMR spectroscopy is inherently quantitative and can be integrated with other spectroscopic techniques currently used routinely in forensic labs. The company also said that the Italian Customs and Monopolies Agency (ADM) recently equipped its regional labs across Italy with benchtop NMR, joining a number of other authorities.
Magritek has offices in Aachen, Philadelphia, and Wellington, New Zealand.
